13F

Stock

Iovance Biotherapeutics, Inc.

IOVA · held by 6 managers

Reported value

$2.1M

Holders

6

+3 new · −1 exited

Holders’ est. mark

−$919K

Price effect on 1 books still in the name

Largest holder

$1.52M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC884.3K$1.52M−$919KCut−$379.8K
Cresset Asset Management, LLC190.3K$327.3KHeld
Leonteq Securities AG95K$163.4KNew
Sanctuary Advisors, LLC34.7K$59.7KNew
Pine Valley Investments Ltd Liability Co18.3K$31.5KNew
Essential Partners LLC418$719Held

Who left

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.